Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.
Kosten
T R
TR
Psychiatry Department, Yale University School of Medicine, New Haven, CT 06519.
Morgan
C
C
Kleber
H D
HD
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002047:Buprenorphine / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D008734:Methoxyhydroxyphenylglycol / Q000097:blood; D009270:Naloxone / Q000627:therapeutic use; D009271:Naltrexone / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000523:psychology / Q000534:rehabilitation; D013375:Substance Withdrawal Syndrome / Q000523:psychology
D009270:Naloxone; D002047:Buprenorphine; D008734:Methoxyhydroxyphenylglycol; D009271:Naltrexone; D008691:Methadone